Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
On-Line Instrument Systems (OLIS) is a private U.S. manufacturer of research-grade spectroscopy and spectrophotometry instruments used in life science and other laboratory settings. The company focuses on UV/Vis, NIR, IR, circular dichroism, circularly polarized luminescence, rapid-scanning, and related analytical systems, along with instrument software, upgrades, accessories, and technical support. Its products are positioned for researchers working with clear, turbid, chiral, and other challenging samples, including protein, cell, and particulate-material applications. OLIS appears to be primarily a tools-and-instrumentation company rather than a therapeutics developer, so it does not have a conventional drug pipeline. The business emphasizes hand-built systems, modular upgradability, long product life, and custom support from its Athens, Georgia base.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on On-Line Instrument Systems.